Review explores GLP-1 receptor agonist potential impact in cancer therapy through anti-proliferative, anti-inflammatory, and metabolic mechanisms.
Key findingReview explores GLP-1 receptor agonist potential impact in cancer therapy through anti-proliferative
What the researchers found
Review explores GLP-1 receptor agonist potential impact in cancer therapy through anti-proliferative, anti-inflammatory, and metabolic mechanisms.
Why it matters
Relevant to peptide therapeutics.
How the study worked
In publication.
What this study cannot tell us
In publication.
How to read the evidence
Based on design.
When this study was published
Published in 2025.
The bigger picture
Advances peptide evidence.
Questions still open
- Long-term implications?
- Evidence comparison?
- Next steps?
Common questions
What does this mean?
How reliable?
Read the original research
Exploring the potential impact of GLP-1 receptor agonists in cancer therapy.
Minerva endocrinology, 50(3), 302-311
Citation
Aslam, Baseer; Bin Zafar, Muhammad D; Changez, Mah I Kan; Abdullah, Muhammad; Safwan, Muhammad; Qamar, Bisma; Shinwari, Abdullah; Rai, Sanjana. (2025). Exploring the potential impact of GLP-1 receptor agonists in cancer therapy.. Minerva endocrinology, 50(3), 302-311. https://doi.org/10.23736/S2724-6507.23.04101-5